Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The document concludes that treating skin conditions should include psychological care and a multidisciplinary approach is essential for effective management.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Some skin conditions are common during pregnancy and can be safely treated without affecting the pregnancy outcome.

Nanofat shows promise for facial rejuvenation and treating skin issues but needs more research for long-term safety.

A cat's skin condition was fully cured with cyclosporine A after other treatments failed.

A girl with type 1 diabetes developed a serious eye condition very early, suggesting the need for earlier eye checks and that early treatment can work well.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Injecting a person's own fat into their scalp may help regrow hair and improve hair thickness in different types of hair loss.

Basonuclin 2 is vital for the development of facial bones, hair follicles, and male germ cells in adult mice, and its absence can lead to dwarfism and abnormal follicles.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Diagnosing and treating PCOS in teenagers is difficult, and the focus is on lifestyle changes and medication to improve health and prevent future issues.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

New treatments for PCOS focus on managing symptoms and improving fertility.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Using one's own fat may help treat hair loss.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Home-use lasers and IPL devices are unlikely to directly cause paradoxical hair growth; it may be linked to inflammation or hormonal issues.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.